IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.274
-0.010 (-3.66%)
At close: Apr 28, 2026, 4:00 PM EDT
0.285
+0.011 (4.13%)
After-hours: Apr 28, 2026, 7:57 PM EDT
IceCure Medical Stock Forecast
ICCM's stock price has decreased by -77.2% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IceCure Medical stock has a target of 2.50, which predicts an increase of 813.74% from the current stock price of 0.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 7, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for IceCure Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $2.5 | Strong Buy | Maintains | $2 → $2.5 | +813.74% | Oct 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $2 | Strong Buy | Maintains | $2.5 → $2 | +630.99% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +813.74% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +813.74% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +813.74% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
8.09M
from 3.38M
Increased by 139.51%
Revenue Next Year
14.22M
from 8.09M
Increased by 75.66%
EPS This Year
-0.19
from -0.24
EPS Next Year
-0.15
from -0.19
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.3M | 21.3M | ||||||
| Avg | 8.1M | 14.2M | ||||||
| Low | 5.0M | 7.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 235.2% | 162.8% | ||||||
| Avg | 139.5% | 75.7% | ||||||
| Low | 47.4% | -7.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.13 | -0.08 | ||||||
| Avg | -0.19 | -0.15 | ||||||
| Low | -0.25 | -0.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.